Qinglong Guo

机构：Nanjing Tech University, China Pharmaceutical University, Anhui Medical University, Simcere Pharmaceutical (China), State Key Laboratory of Natural Medicine · ORCID：0000-0001-5165-2592

发表论文 388 篇 · 总被引 13464 次 · h-index 62

代表论文

Development of highly potent and specific AKR1C3 inhibitors to restore the chemosensitivity of drug-resistant breast cancer (2022 · European Journal of Medicinal Chemistry · 被引 24)
AFP deletion leads to anti-tumorigenic but pro-metastatic roles in liver cancers with concomitant CTNNB1 mutations (2023 · Cancer Letters · 被引 22)
Targeting lysosomal HSP70 induces acid sphingomyelinase‐mediated disturbance of lipid metabolism and leads to cell death in T cell malignancies (2023 · Clinical and Translational Medicine · 被引 22)
Oroxylin a promoted apoptotic extracellular vesicles transfer of glycolytic kinases to remodel immune microenvironment in hepatocellular carcinoma model (2023 · European Journal of Pharmacology · 被引 18)
Development of Biaryl-Containing Aldo-Keto Reductase 1C3 (AKR1C3) Inhibitors for Reversing AKR1C3-Mediated Drug Resistance in Cancer Treatment (2023 · Journal of Medicinal Chemistry · 被引 18)
Paclitaxel combined with Compound K inducing pyroptosis of non-small cell lung cancer cells by regulating Treg/Th17 balance (2024 · Chinese Medicine · 被引 12)